JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 18

www.koreanglaucoma.org

17

9ROXPH_1XPEHU

ৢߜܾࣳ৊৒ઊ૒઻ٻ଒ৌң֢ஷѿહઌ৊৒ടҋઊച੄

ഡפֳણ൝ઘਁ़ؘࣳीહௗݑݴӋܱനৡഡد৊৒੹֯ஷ Ԟ੥ഡ़ीહௗݑؘد৩ട଒ކെથפֳણઅ़ीહௗݑܾ

ࣳއઊ१രٻӋઔؘҫ੸ࣼ੭૲઻ૂीӘࠒ़੭஺ણௗࣘ઒

ीઊدفࡘ࡚અीઘڝ੸़ीઊച੄ഡפֳણ൝ઘઅઍୱહ

ௗݑܾࣼ੭૲઻ૂी੹ࣷ൑ടؘٙԓѿણిઊ੭ؘࣼ੭૲઻

ૂीઊ५ೂഡઊ൲ਁؘࠒ़੭஺ણௗࣘ઒ी੹१രഢ़ઔ଒ކ

ࠒ़੭஺ણௗࣘ઒ीઊऀӖહઊ଒߆ഢӄੌਁؘد१ࣼ੭૲઻

ૂी੹१രടؘҫઊඩڝԞڹߚઊ܅ӋࣥҀനࡆ़ઔدԓܟ

ܾ߳ऀӖઅѿ؟ऀઊઔد޷ࠒ़੭஺ણௗࣘ઒ीࡂدؘࣼ੭૲

઻ૂीઊًࣷ൑ٻӋઔ੶޵ࠒ़੭஺ણௗࣘ઒ी੸دݳ஋ௗ

ѿ࡜ѿ؟ഢڹ१രട٩ܿઊୱહઌௗݑࠒ৊੶ܾ֪Һڂؘӄ ലઊઔدട଒ކࡻܿણԞҁઅӄӘӚ୵ઊച੄ടҸ଒ކமԕ

ࠋ೵ٻӋઔؘد৩ഡઑࣛ਌Ӵਁࣳࠒ़੭஺ણௗࣘ઒ी੹ઍୱ

़ीܾࣷ౗ടؘҫ٩ട֢અࣷ౗ઊٽ़ઔدؘҿӘڝઊࠋ೵

ٻӋઔ੶޵़ीઊച੄ഡפֳણ൝ઘਁࣳࠒ़੭஺ણௗࣘ઒ी

੹ࣷ౗ടؘҫ੸़ीઘઅӄസӘࣷ൑٩ਁگݳࣷ౗ઊٽ़ઔ د५ૂܾഡࡂӋਁઅട޷ךਁؘ߸ӵਁࣳਁ࡜Әട

َࠒ़੭஺ણௗࣘ઒ीઅࡻૻઊךਁؘܾ଑ѿടਔ د

৊৒੹֯ஷԞ੥ഡפֳણ़ीܾࠒ़੭஺ણௗࣘ઒ी੹ҿ

ીടӋ१രതਁઔৰ़ीઅऀӖ੹੥നѿણޣસӋܱനৡഢ

ҫ੸़ी൲஢Ԟਁࠋࣥഢ़ઔؘસ৊৒Ә़ी൲ৰؖી٩

१ҁઊӄӘഡ൲ࠋࣥഢ़ઔؘӋ৊৒ઊدࠒ़੭஺ણௗઅસ ധઊா࡚ട଒߆ഢӄੌࠒ़ѿ଒֢ௗҲއઊ੭஺پ੶ܾঅસ

৊৒઺ࠒघ५ڢઅഥ࠾଑ઊࠋࣥഢ़ઔ੶޵़ी൲़૲ѿ

ӄӘടҲٻ޷ࠒ़੭஺ણௗઅSODWH૲੥ܾઽୱહઌࣼ੭൛ѿ

ઊݗৰ଒޷ࣳࠒ़੭஺ી٩ݴҿીടؘસധऀઅ࠸੶ܾઙੋ

ടҲټدؘҫઊدઊܟഡࣼ੭ऀ֮೩ѿࣥऀٻԞ઺ઌ़ी஢

Ԟਁؘࠒ़ѿ଒֢ௗҲࢉݼ੭஺ٻৰસ৊৒੶ܾઌഡഥ࠾଑ઊ

ࠋࣥഢ़ઔ੶޵़ी൲१ҁઊӄӘതਁگ܅֮೩ѿൌऀٻ޷

ࠒ़੭஺ઊ૵ৰڝ޷ࣳ࡜ா࡚ഡ৊৒૒઻ઊٽ़ઔدؘҫ੹

ࠉڙ१ࣥҀടӋ൝ઘѿ़ी൲஢Ԟਁસ৊৒੹ҽڨ़ઔؘࣛ

ൠઌ଒ԓݼӋણԞહઌ޿೵৊৒੸ৰؖી٩ઌ଒ਁگ܅ࠒ़੭

஺ણௗࣘ઒ी੹ҿીനৡഡد

ӯӘࣳહઌࠒ़੭஺ણௗࣘ઒ीઅહ੾଑੹ࣔೞࡂ޷)LJXUH

ਁࣳਭҎઊDQWLPHWDEROLWHѿ࣏ੋٻԞઊ઺ਁؘߗ़ીஔ൒੸

੥़ીஔ৊ਁࣳઅפֳણҿޅઅ७ഡࣼ੭ऀࠉඕઊઔ੹ڹ೩ ٩ޅਐ੶ܾઌഡઊୱऀפֳણ३ࣥേӚפֳણҀޅઊ२ीઊ

൲ࠋࣥഡפֳણࣷ஍ऀפֳણLULGRFRUQHDOG\VWURSKLHVԓݼ Ӌઊ઺અפֳણ़ीઊ५ೂടਔ੹ڹી٩ܾӵഡٻৰઔৼ੶

֢ࣼ੭૲઻ૂीਁDQWLPHWDEROLWHѿ࣏ੋٻৰऀӖݬઊ׬ৈ଒

޷ࣳહ੾଑ઊ)LJXUHਁࣳਭҎઊ૗ًӵഡٻৼد


नࢤആҙ
֣ղ੢ /7(

ઍࠉહઌৢߜௗݑਭܩઊસௗݑਁࠉ੾ട଒ৌؘ19*൝ઘਁ

ઔৰࣳࠒ़੭஺ણௗࣘ઒ीઊ੭ੋടدӋ্ܱ૊ઔ੶޵ಡඥ

ࣼ੭૲઻ૂीઊ५ೂഡઊ൲ਁؘࠒ़੭஺ણௗࣘ઒ी੹ੌࣷહ

੶ܾӋܱനৡഡدӋ্ܱ૊ઔد7VDL-&HWDO2SKWKDOPRORJ\

$KPHGYDOYHਭ0ROWHQRLPSODQWઅ़ी൲ऀӖݬ੸஋

੻ਁؘࣛفહ੶ܾ૝੶़֢ी൲१ҁઊ଒֪ਁگ܅ઽઽऀӖ ಡଙפֳણઅ࠾ઌଔزௗݑ

,QGLFDWLRQVIRU*ODXFRPD,PSODQW6XUJHU\

৊થ൙

ᦥᵝݡ⦺Ʊ
᮹ŝݡ⦺
ᦩŝ⦺Ʊᝅ

Fig. 1. ࠒ़੭஺ણௗࣘ઒ीઅહ੾଑અ࠹൛

Journal of The Korean Glaucoma Society

JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 18

ݬઊۅৰ଒޵ҿӘѿ૝଒ৌدӋࡂӋٻৼد%DHUYHOGWLPSODQW

ਊ१19*અௗݑਁઔৰࣳ൭Әહઊ଒ކ઼੸൝ઘ़֢ी઺१

ܲઊ૝଒ৌ੸ӄੌ੭஺ણௗࣘ઒ीઊ५ೂഢѿ؟ऀઊً׬د 6LGRWL3$HWDO2SKWKDOPRORJ\19*൝ઘઅӄੌ੭ݼஔ

઻ૂी੹१രഡӄੌ೤޷ࡘݴ౿ഡࠒ़੭஺ણௗࣘ઒ीઊ़

ीઅऀӖݬ੹׬ઊؘٙ٩੒ઊټد


"QILJD
BOE
1TFVEPQIBLJD
FZF

़ીஔ৊ਁࡻനߗ़ીஔ৊ԓݼӋઌӖ़ીஔ৊੸Ӌ२હ ઌࣼ੭૲઻ૂीઅऀӖݬઊ֯੸ҫ੶ܾઝ্ܱ૊ઔدߗ़

ીஔ৊ӘઌӖ़ીஔ৊ਁࣳҀ૚פֳણ़ीઅऀӖݬ੹ࡻӯ ടਔ੹ڹࠒ़੭஺ણௗࣘ઒ीઅऀӖݬઊࣼ੭૲઻ૂ

ीࡂد׬৔੶޵:LOOLDP$HWDO2SKDOPRORJ\

ך഑ݼڙކڢ੸0ROWHQRણௗݴઊੋനඔઌઌӖ़ીஔ৊ԓ ݼӋߗ़ીஔ৊൝ઘਁҲࠒ़੭஺ણௗࣘ઒ी੹१രടਔӋ

ґਖ਼ପऀӖݬ੸܅ӋࡂӋടਔد)UHHGPDQ-HWDO$UFK

2SKWKDOPRO


6WFJUJD
(MBVDPNB

೩ ٩ ޅ ਐ ਁ  ٳ ࠉ ټ  פ ֳ ણ અ  ӄ ੌ  ࣼ ੭ ૲ ઻ ૂ ी ੸

DQWLPHWDEROLWHݴ࣏ੋട଒ৌ੹ӄੌऀӖݬઊۅৰ଒ؘҫ੶ܾ

্ܱ૊ઔ੶޵7RZOHU+0HWDO2FXODU,PPXQRO,QIODPP ಡඥ਌घऀӚ઻ਐӘٳࠉټ೩٩ޅਐઊ֢ઊ઺અࣼ੭૲઻ૂी

ઊ५ೂഡӄੌߗ़ીஔ৊५ݼఒਠઍઊ࣏ੋٻৼَ؁ԓݼӋ

३ࣥേӚઊઔؘӄੌਁؘࠒ़੭஺ણௗࣘ઒ी੹१രടؘҫઊ

ً૝دӋ্ܱ૊ઔد8YHLWLF*ODXFRPD൝ઘਁ࣏ࣳੋټࠒ़

੭஺ણௗؘ$KPHGYDOYH0ROWHQRLPSODQW%DHUYHOGWLPSODQW

ਁࣳ޾ڂ৊৒૒઻ઊઝٻৼدӋࡂӋٻৼد0ROWHQR$&HWDO

2SKWKDOPRORJ\&HEDOORV(0HWDO2SKWKDOPRORJ\

'D0DWD$HWDO2SKWKDOPRORJ\


$POHFOJUBM
(MBVDPNB

െથԪ଒ࡂӋټࠅਁઅട޷ৰݾઊਁࣳઅӋ२હઌࣼ੭૲઻

ૂीઅऀӖݬ੸ਁܾࣳऀઌਁࡻന֯੸ҫ੶্ܾܱ

૊ઔ੶޵:DOODFHHWDO2SKWKDOPRORJ\*UHVVHOHWDO

2SKWKDOPRORJ\JRQLRWRP\֢WUDEHFXORWRP\ѿ५ೂഡӄ

ੌԓݼӋ,ULGRFRUQHDOG\VJHQHVLV$QLULGLD$SKDNLD6WXUJH

:HEHUV\QGURPHઊઔؘӄੌਁؘࠒ़੭஺ણௗࣘ઒ीઊًࣷ

൑ٻӋઔد$QWLPHWDEROLWHVؘघৈਁࣳ૲અന࣏ࣳੋനৡട

़ؘٙी൲१ҁઊӄӘതਁگ܅ਉӘ೩਼࠸ઊ৥ৈଖ़ઔ

Table 1.$KPHGYDOYHਭ0ROWHQRLPSODQWઅણԞહઌऀӖݬࡻӯ

1 year 2 year 3 year 4 year 5 year

Ahmed valve 63.2% 56.2% 43.2% 37.8% 25.2%

Molteno implant 37.0% 29.6% 29.6% 29.6% 29.6%

<DOYDFHWDO(\H

Table 2.,QWUDRFXODUSUHVVXUHDQGPHGLFDOWKHUDS\LQWKH7XEH9HUVXV7UDEHFXOHFWRP\6WXG\

Tube group Trabeculectmoy P -value

Baseline

IOP (mmHg) 25.1 ± 5.3 25.6 ± 5.3 0.56

Glaycina medications 3.2 ± 1.1 3.0 ± 1.2 0.17

1 year

IOP (mmHg) 12.5 ± 3.9 12.7 ± 5.8 0.73

Glaycina medications 1.3 ± 1.3 0.5 ± 0.9 <0.001

2 year

IOP (mmHg) 13.4 ± 4.8 12.1 ± 5.0 0.101

Glaycina medications 1.3 ± 1.3 0.8 ± 1.2 0.016

3 year

IOP (mmHg) 13.0 ± 4.9 13.3 ± 6.8 0.78

Glaycina medications 1.3 ± 1.3 1.0 ± 1.5 0.30

4 year

IOP (mmHg) 13.5 ± 5.4 12.9 ± 6.1 0.58

Glaycina medications 1.4 ± 1.4 1.2 ± 1.5 0.33

5 year

IOP (mmHg) 14.4 ± 6.9 12.6 ± 5.9 0.12

Glaycina medications 1.4 ± 1.3 1.2 ± 1.5 0.23

www.koreanglaucoma.org

19

9ROXPH_1XPEHU

ӋԓܾઌനਉӘ೩ਐ֢ৈѿ৊ֳਐઊࣥԢ़ઔԞڹߚઊد

%HFNڢઅࡂӋਁઅട޷ಡඥंઊടઅ൝ઘਁࣳࣼ੭૲઻ૂ

ीઅऀӖݬઊ़ी൲ךପਁؘךପਁؘܾঅࠒ़

੭஺ણௗਁࡻനെસඥ֯৔د%HFNHWDO$P-2SKWKDOPRO




1SFWJPVT
(MBVDPNB
TVSHFSZ

פֳણ़ीઊ઺અ৊Ӵ़ीܾઌന੯ࡘҿޅਁ୺ࣛࠉ੾ઊ

੭ࠋٻৰࣼ੭ऀࠉඕઊࣥԞ޷ࣼ੭૲઻ૂीઅऀӖݬઊെસ ඥۅৰ଒Ҳټدࠒ़੭஺ણௗؘઊ઺અࠒ़੭஺ણௗࣘ઒ी

ઊ५ೂഡڎਁ٩Ӌܱഢ़ઔ़ؘٙीࡘ੥અࣼ੭൛ѿࠋࣥ

ടܾ߳Ҏ੸TXDGUDQWਁد१ࣘ઒ട޷ࣼ੭൛ࠉ੾ઊ੍ًҋ ടҲࠋࣥടܾ߳ࠉڙ१دݳTXDGUDQWݴઊੋടਉࠒ़੭஺ણ

ௗࣘ઒ी੹࣏ੋനৡഡدҁ൒3LJJ\EDFNJODXFRPDLPSODQW

ݴӋܱഢ़٩ઔؘٙઊؘ৊Ӵઅ޾ڛTXDGUDQWѿࣼ੭൛

ઊ઺અ ࠒ़੭஺ણௗࣘ઒ी ڢ੶ܾ ़ीਁ હഥട଒ ߆ട޵

&\FORSKRWRFRDJXODWLRQઅહ੾଑٩ٻ଒ৌؘ൝ઘਁࣳӋܱന

ࡆ़ઔد3HGLDWULFVL]HGJODXFRPDLPSODQWݴઊ઺़ीഡࣼ

੭൛ټਉӘ೩੥ୄ੶ܾࣘ઒ട޵৊Ӵ੎ٳણ৘ѿࡽࠤടҲࠋࣥ

ഢ़ઔ੶ܾ߳৩৊१ѿ੭଒ٻӋઔؘ൝ઘਁؘࣳ३ૻടҲҿ

ીനৡഡد


1BUJFOU
SFRVJSJOH
B
,1

৊৒૒઻ઊமفৢߜௗݑܾ૒઻ٻӋઔؘ൝ઘਁࣳ.3ݴ१ രടҲٻ޷़ी൲৊৒૒઻ઊ৊ٻ޵פֳણઊࡽࠤടҲ৉൛ ٻؘҫ੹ࡆ़ઔدઊܟഡӄੌࣼ੭૲઻ૂीࡂدؘ.3ਭٳ १ਁࠒ़੭஺ણௗࣘ઒੹Ӌܱനৡട޵़ी൲७Ҁഡસ৊৒

੶ܾઌനҀޅઊ२ઊ५ೂടؘҫ੹ޅԞ੥ന9DOYHѿઔؘࠒ़

੭஺ણௗݴࣷ౗ടؘҫઊ૝د


5SBCFDVMFDUNPZ
WT
"INFE
(MBVDPNB
7BMWF

ך:LOVRQ੸޻અ൝ઘݴفࣛ੶ܾࣼ੭૲઻ૂीӘ

$KPHGࠒ़੭஺ણௗઅऀӖݬ੹ࡻӯടؘઑࣛ਌Ӵݴ१രടਉ

ࠋ೵ടਔؘٙ৊৒ઊઊടܾ૒઻ٻң֢ઊࣛઅ৊৒ടҋ

੹ऀӖઊ܅Ӌીઅടਔ੹ڹڂ़ी੸ਭܾࡻ॥ഡऀ

Ӗݬ੹ࡂਔ଒ކ$KPHGJURXSਁࣳஷѿહઌ৊৒ҋടݴ੥ഡ

ৢߜௗݑѿًച੄ഡҫ੶ܾ֢ౌ֭د१രഡ़ीઊઍୱ़ीઊ ৼؘ଒ৈإ޷ઊ઺અ़ीܾ৊৒૒઻ઊٻ଒ৌৈୱܾ१രഡ

़ीઊৼؘ଒़ؘी൲ऀӖݬઅୱઊਁਕല੹ࡂઊ଒ৌ৔د

ԓݼӋךڎࠋ೵ټણԞ)8GDWDਁࣳ٩ڂԓݜ੸৊৒૒઻ਁ

ઔৰࣳୱઊݴࡂઊ଒ৌ৔د:LOVRQHWDO


5VCF
WT
5SBCFDVMFDUPNZ
4UVEZ

7XEHYV7UDEHFXOHFWRP\6WXG\ؘ797VWGX\JURXSਁઅ ന ࣼ੭૲ ઻ૂीӘ %DHUYHOGW ,PSODQWઅ ऀӖݬ੹ ࡻӯഡ

PXOWLFHQWHUFOLQLFDOWULDOܾঅઍୱऀؘۙ19*೩٩ޅਐڢਐ

଑੶ܾઌഡӄੌݴૂ਼ഡઊୱऀפֳણ൝ઘݴفࣛ੶ܾട ਔ੶޵ઊ઺ਁࣼ੭૲઻ૂीઊ५ೂടਔң֢ࠕֳણ़ी੹ࠊ

੸़ीԞਵܲઊઔؘ൝ઘݴߗઙ੥ܾ%DHUYHOGWLPSODQWRU

WUDEZLWK00&PJPO[PLQXWHVӶ੶ܾ֢׿ৰࠔીട ਉך$-2ਁ஋੻ࡂӋټઊܑךךԓݼӋךਁך

)8GDWDѿࠋ೵ٻৼد੥਌ӴઅҿӘݴ੄ৢട޷د੻ӘҎ د797VWXG\JURXS$P-2SKWKDOPRO

ךҁઅ)8Ԟҁ੹׭Ӌࡂ৔੹ڹڂ़ीࠩ੸޾ڂா࡚ഡ

৊৒ҋട൭Әݴ৴੹़ઔৼدࡻ़ܿी൲஑ґਖ਼ਁؘࣼ

੭૲઻ૂीӶઅ৊৒ઊെસടҲ֯৔଒ކґਖ਼ڎࡘౡؘڂ

Ӷҁઅୱઊݴࠋҽഢ़৺ৼدસઘڝ੸ઊ઺અ਌Ӵਁࣳࠒ

़੭஺ણௗࣘ઒ीઅऀӖݬઊً֯৔َҫ੸૲ܾفࣛ൝ઘࣷ

౗ਁઔৰࣳઅ࡜ݼത੹Ӌܱട଒ৌӋ࡚ࣴടਔԞڹߚઊ܅Ӌࣹ

޻ടӋઔد797VWXG\ਁؘࣳߗઙ੥ܾ൝ઘѿҀӶਁࠔીٻৼ Ӌ19*$SKDNLDLQIODPPDWRU\QGDU\JODXFRPDڢઊفࣛਁ

ࣳૂ਼ٻৰࡂ౿੭஺ણௗݴӋܱടҲٻؘ൝ઘઅӄੌࡂدفࣛ

൝ઘઅ5LVNIDFWRUѿ֯৔੶޵ಉ޻Ҁޅ઻ґݴ౿ഡࠕֳણ़ी੹

१രഡ൝ઘކ੹فࣛ੶ܾടਔدઊਁસઘڝ੸فࣛ൝ઘࣷ౗ਁ

ઔৰࣳઅ࡜ݼതઊ৺د޷ڂ़ी੸ણԞહ੶ܾࡻ॥ഡ৊৒૒઻

൭ӘݴѿଔدӋҿֳ݀ݼӋઔد

़ी൲஑ךҁ੸ࠒ़੭஺ણௗࣘ઒Ӷਁࣳ৊৒૒઻੹੥

ന੭અടҲًއ੸৊৒ടҋૂѿച੄ടਔ଒ކًણԞહ੶ܾ

Ӛ୵ടਔ੹ڹڂӶҁਁୱઊݴࡂઊ଒ৌ৔د़ी൲ࠒ़੭

஺ણௗࣘ઒Ӷਁࣳച੄ഡ৊৒ҋടૂઅ़ؘి࠹൛ݴࡂઊ଒

ৌ੸ࠉ޷ךઊӄӘട޷ࣳࣼ੭૲઻ૂीӶਁًࣳއ੸৊৒ҋ ടૂѿച੄ടҲٻ޷ࣳךପࡘౡؘڂӶҁઅୱઊѿ৺ৰ૏د

ऀӖݬઊৈا५ೂݴԞ૴੶ܾࣔೞࡂ৔੹ڹࣼ੭૲઻ૂी

Ӷ੸ࠒ़੭஺ણௗӶࡂدً׬੸़ी५ೂੰ੹ࡂਔد,23⾚

PP+JԓݼӋUHGXFHG,23OHVVWKDQ੹५ೂ܅Ӌીട ਔ੹ڹ׿હ५ೂੰ੸ךପਁࣼ੭૲઻ૂीӶਁࣳԓݼӋ

੭஺ણௗӶਁܾࣳ੭અഡୱઊݴࡂਔد५ૂ़ी൲൝ ઘਁҲച੄ഡ޿೵৊৒੸ઊࡂدً֯੶ܾ߳५ೂઅԞ૴੹ً

Journal of The Korean Glaucoma Society

JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 20

֯ஷৰPP+Jࠅճৼ੹ڹ٩ࣼ੭૲઻ૂीӶਁࣳԓݼ Ӌ੭஺ણௗӶਁܾࣳ੭અഡୱઊݴࡂਔ੶޵PP+Jܾ

֯ஷৼ੹ڹਁ٩ࣼ੭૲઻ૂीӶਁࣳԓݼӋ੭஺ણௗӶ

ਁܾࣳ੭અഡୱઊݴࡂਔد

ךପ׿હથ़ीࡻੰ੸੭஺ણௗӶਁࣳࣼ੭૲઻ૂी

Ӷਁܾࣳࣼ੭૲઻ૂीӶਁًࣳ׬৔د

१ܲ੸%DVHOLQHӘ़ी൲ךӄӘ१ઽਁࣳ޾ڂڂӶਁࣳ

ୱઊݴࡂઊ଒ৌ৔د

़ी൲ഥ࠾଑੹ࣔೞࡂ৔੹ڹ஑ഡش੸ࣼ੭૲઻ૂीӶ

ਁًࣳ׬੸ഥ࠾଑ઊࠋҽٻৼ੶֢شઊ൲ךԪ଒़ी൲Ԟ

ഥ࠾଑ਁؘࣳڂӶҁୱઊݴࡂઊ଒ৌ৔੶޵૒઻੹੥ന़ी

ઊച੄ഢી٩ઊң֢१ܲઅെસഡ҆घݴઍ੶ేކుૻഡഥ

࠾଑અࠋࣥ٩ڂӶҁਁୱઊݴࡂઊ଒ৌ৔د:RXQGOHDNV

EOHEOHDNV҆Ҁઊࣛڢઅഥ࠾଑੸ࣼ੭૲઻ૂीӶਁࣳඕട޵

़ी൲৊Ӵ੎ٳણ৘ڢઅഥ࠾଑੸੭஺ણௗӶਁࣳ׬৔د

797VWXG\ؘઊ઺અ਌Ӵਁࡻന੭஺ણௗࣘ઒ीઅ੭ੋऀઊ

އઊࡘҀٻৼؘٙ&DSULOROLؘસઘڝઊҁӘടਔң֢פֳણ़

ीӋܱ१797VWXG\ਁઅ૔നؘࣳ৊ٻؘઊ੭ਁفനد੻Ә

ҎઊԞीടਔؘٙࠒ़੭஺ણௗؘܾ/RZWHHQઊടઅ৊৒੹

৴ԞඩڝԞڹߚਁ৊৒૒઻ௐ޷ਁࣳࣼ੭૲઻ૂीࡂد੭஺ણ

ௗؘੌ़ടدӋഢ़৺੶޵797VWXG\ਁࣳ஋ܣ7UDEઅഥ࠾

଑ઊً׬଒ৌ੶޵ಡඥ%DHUYHOGW੭஺ણௗਁًࣳއઊࠋࣥ

ടؘ৊Ӵ੎ٳણ৘ؘޓੌ७Ҁഡߚૂݴ੭ࠋട޵ஷહӚ୵Ԟ ҁઊࡘઙੋӘऀӖݬ੹ץടԞਁৈଓତ੶޵7XEHHURVLRQڢ

ણԞહ੶ܾࠋࣥഢ़ઔؘഥ࠾଑ઊਉ઺ඥ૔થഡدۙഡفࣛ

൝ઘؘࠕֳણ़ीઊ֢ࣼ੭૲઻ૂी੹ઊ߸ࠊ੸൝ઘݴفࣛ

੶ܾടਔԞڹߚਁৰۄ़ी٩ࠊ଒ৌ੸ӄੌਁفഡࣹ޻੸ٽ

़৺੶޵QRQYDOYHGSODWHઌ%DHUYHOGWކ੹فࣛ੶ܾടਔԞਁ

੭஺ણௗ઺ஔܾઊҿӘݴࠉਕടؘؘٙߗݼѿگݴ़ઔدӋ

ടਔد&DSULROL-$P-2SKWKDOPRO

요 약